- Investing Ideas
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
8
Companies with a Value score of at least 3, ordered by Value score
8 companies
Amgen
Market Cap: CL$224.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGNCL
CL$382,280.00
7D
3.6%
1Y
30.3%
Gilead Sciences
Market Cap: CL$171.6b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDCL
CL$121,920.00
7D
0.5%
1Y
54.3%
Amgen
Market Cap: US$224.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$417.20
7D
10.1%
1Y
63.5%
Gilead Sciences
Market Cap: US$171.6b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$133.06
7D
1.5%
1Y
20.5%
Johnson & Johnson
Market Cap: US$627.4b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$261.81
7D
2.9%
1Y
57.5%
Johnson & Johnson
Market Cap: CL$627.4b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJCL
CL$239,900.00
7D
2.0%
1Y
42.2%
Eli Lilly
Market Cap: US$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,231.90
7D
10.0%
1Y
88.8%
Eli Lilly
Market Cap: CL$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLYCL
CL$1,128,800.00
7D
10.7%
1Y
73.0%